Article info
Original article
CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors
- Correspondence to: C Monteagudo Departamento de Patología, Facultad de Medicina, Avda Blasco Ibanez 15, 46010 Valencia, Spain; Carlos.Monteagudo{at}uv.es
Citation
CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors
Publication history
- Accepted October 13, 2005
- First published March 7, 2006.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
- latest version (25 October 2017).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 Journal of Clinical Pathology